Women who use bisphosphonates — medications commonly used to treat osteoporosis and other bone conditions — have about half the risk of developing endometrial cancer as women who do not use the drugs, a new analysis shows.
Women who use bisphosphonates — medications commonly used to treat osteoporosis and other bone conditions — have about half the risk of developing endometrial cancer as women who do not use the drugs, a new analysis shows.